Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation - PubMed (original) (raw)
Comparative Study
. 2006 Jan 15;176(2):1053-61.
doi: 10.4049/jimmunol.176.2.1053.
Stéphane Claverol, Fanny Piette, Wenbin Ma, Vincent Stroobant, Benoît Guillaume, Jean-Edouard Gairin, Sandra Morel, Odile Burlet-Schiltz, Bernard Monsarrat, Thierry Boon, Benoît J Van den Eynde
Affiliations
- PMID: 16393993
- DOI: 10.4049/jimmunol.176.2.1053
Comparative Study
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation
Jacques Chapiro et al. J Immunol. 2006.
Abstract
The immunoproteasome (IP) is usually viewed as favoring the production of antigenic peptides presented by MHC class I molecules, mainly because of its higher cleavage activity after hydrophobic residues, referred to as the chymotrypsin-like activity. However, some peptides have been found to be better produced by the standard proteasome. The mechanism of this differential processing has not been described. By studying the processing of three tumor antigenic peptides of clinical interest, we demonstrate that their differential processing mainly results from differences in the efficiency of internal cleavages by the two proteasome types. Peptide gp100(209-217) (ITDQVPSFV) and peptide tyrosinase369-377 (YMDGTMSQV) are destroyed by the IP, which cleaves after an internal hydrophobic residue. Conversely, peptide MAGE-C2(336-344) (ALKDVEERV) is destroyed by the standard proteasome by internal cleavage after an acidic residue, in line with its higher postacidic activity. These results indicate that the IP may destroy some antigenic peptides due to its higher chymotrypsin-like activity, rather than favor their production. They also suggest that the sets of peptides produced by the two proteasome types differ more than expected. Considering that mature dendritic cells mainly contain IPs, our results have implications for the design of immunotherapy strategies.
Similar articles
- Analysis of the processing of seven human tumor antigens by intermediate proteasomes.
Guillaume B, Stroobant V, Bousquet-Dubouch MP, Colau D, Chapiro J, Parmentier N, Dalet A, Van den Eynde BJ. Guillaume B, et al. J Immunol. 2012 Oct 1;189(7):3538-47. doi: 10.4049/jimmunol.1103213. Epub 2012 Aug 27. J Immunol. 2012. PMID: 22925930 - Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.
Dalet A, Stroobant V, Vigneron N, Van den Eynde BJ. Dalet A, et al. Eur J Immunol. 2011 Jan;41(1):39-46. doi: 10.1002/eji.201040750. Epub 2010 Dec 9. Eur J Immunol. 2011. PMID: 21182075 - A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.
Ma W, Vigneron N, Chapiro J, Stroobant V, Germeau C, Boon T, Coulie PG, Van den Eynde BJ. Ma W, et al. Int J Cancer. 2011 Nov 15;129(10):2427-34. doi: 10.1002/ijc.25911. Epub 2011 Apr 20. Int J Cancer. 2011. PMID: 21207413 - Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity.
Vigneron N, Van den Eynde BJ. Vigneron N, et al. Curr Opin Immunol. 2012 Feb;24(1):84-91. doi: 10.1016/j.coi.2011.12.002. Epub 2011 Dec 27. Curr Opin Immunol. 2012. PMID: 22206698 Review. - Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.
Lázaro S, Gamarra D, Del Val M. Lázaro S, et al. Mol Immunol. 2015 Dec;68(2 Pt A):72-6. doi: 10.1016/j.molimm.2015.04.014. Epub 2015 May 23. Mol Immunol. 2015. PMID: 26006050 Review.
Cited by
- Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.
Ito M, Koido S, Iwamoto T, Morimoto S, Fujiki F, Sugiyama H, Matsumoto S, Effenberger C, Kiyotani K, Shiba K. Ito M, et al. PLoS One. 2024 Aug 8;19(8):e0308330. doi: 10.1371/journal.pone.0308330. eCollection 2024. PLoS One. 2024. PMID: 39116074 Free PMC article. - Sliding Window INteraction Grammar (SWING): a generalized interaction language model for peptide and protein interactions.
Omelchenko AA, Siwek JC, Chhibbar P, Arshad S, Nazarali I, Nazarali K, Rosengart A, Rahimikollu J, Tilstra J, Shlomchik MJ, Koes DR, Joglekar AV, Das J. Omelchenko AA, et al. bioRxiv [Preprint]. 2024 May 4:2024.05.01.592062. doi: 10.1101/2024.05.01.592062. bioRxiv. 2024. PMID: 38746274 Free PMC article. Preprint. - Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing.
Soh WT, Roetschke HP, Cormican JA, Teo BF, Chiam NC, Raabe M, Pflanz R, Henneberg F, Becker S, Chari A, Liu H, Urlaub H, Liepe J, Mishto M. Soh WT, et al. Nat Commun. 2024 Feb 7;15(1):1147. doi: 10.1038/s41467-024-45339-3. Nat Commun. 2024. PMID: 38326304 Free PMC article. - Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Ade CM, Sporn MJ, Das S, Yu Z, Hanada KI, Qi YA, Maity T, Zhang X, Guha U, Andresson T, Yang JC. Ade CM, et al. J Immunother Cancer. 2023 Sep;11(9):e007097. doi: 10.1136/jitc-2023-007097. J Immunother Cancer. 2023. PMID: 37758652 Free PMC article. - Brain-Derived 11S Regulator (PA28αβ) Promotes Proteasomal Hydrolysis of Elongated Oligoglutamine-Containing Peptides.
Kriachkov VA, Gotmanova NN, Tashlitsky VN, Bacheva AV. Kriachkov VA, et al. Int J Mol Sci. 2023 Aug 26;24(17):13275. doi: 10.3390/ijms241713275. Int J Mol Sci. 2023. PMID: 37686081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous